|
| 36525544 | Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV. | AIDS | 2023 |
| 35975297 | Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV). | Clin Infect Dis | 2023 |
| 36101518 | Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States. | Clin Infect Dis | 2023 |
| 37869406 | Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus. | Open Forum Infect Dis | 2023 |
| 36966617 | Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV. | EBioMedicine | 2023 |
| 36825498 | Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE). | Clin Infect Dis | 2023 |
| 36805331 | Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV. | JCI Insight | 2023 |
| 37439633 | Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort. | Clin Infect Dis | 2023 |
| 36998633 | Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency Virus. | Open Forum Infect Dis | 2023 |
| 37368931 | Associations of Muscle Density and Area With Coronary Artery Plaque and Physical Function. | J Acquir Immune Defic Syndr | 2023 |
| 36462699 | The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial. | Contemp Clin Trials | 2023 |
| 37503623 | Hepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIV. | AIDS | 2023 |
| 37486775 | Pitavastatin to Prevent Cardiovascular Disease in HIV Infection. | N Engl J Med | 2023 |
| 35147583 | Prevalence and Correlates of Electrocardiographic Abnormalities in Adults With HIV: Insights From the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE). | J Acquir Immune Defic Syndr | 2022 |
| 35967371 | Methotrexate Inhibits T Cell Proliferation but Not Inflammatory Cytokine Expression to Modulate Immunity in People Living With HIV. | Front Immunol | 2022 |
| 35876637 | Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease risk. | AIDS | 2022 |
| 35413022 | Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV. | J Acquir Immune Defic Syndr | 2022 |
| 35535576 | Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy. | J Infect Dis | 2022 |
| 34794178 | COVID-19 Vaccination Rates in a Global HIV Cohort. | J Infect Dis | 2022 |
| 35257600 | Incorporating estimands into clinical trial statistical analysis plans. | Clin Trials | 2022 |
| 35235653 | Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy. | Clin Infect Dis | 2022 |
| 35179037 | Grayscale Ultrasound Texture Features of Carotid and Brachial Arteries in People With HIV Infection Before and After Antiretroviral Therapy. | J Am Heart Assoc | 2022 |
| 35165682 | Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk. | Clin Infect Dis | 2022 |
| 34888395 | Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus. | Open Forum Infect Dis | 2021 |
| 33693678 | Impact of pre-existing drug resistance on risk of virological failure in South Africa. | J Antimicrob Chemother | 2021 |
| 34134131 | Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial. | Clin Infect Dis | 2021 |
| 34185068 | Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention. | JAMA Netw Open | 2021 |
| 33068427 | Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial. | J Infect Dis | 2021 |
| 33327750 | Effects of HIV Infection on Arterial Endothelial Function: Results From a Large Pooled Cohort Analysis. | Arterioscler Thromb Vasc Biol | 2021 |
| 33177476 | Methotrexate Decreases Tenofovir Exposure in Antiretroviral-Suppressed Individuals Living With HIV. | J Acquir Immune Defic Syndr | 2020 |
| 32022230 | Erratum to: Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir. | J Infect Dis | 2020 |
| 32160827 | Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: critical role of central coordination. | HIV Res Clin Pract | 2020 |
| 32645164 | An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus. | J Infect Dis | 2020 |
| 32645163 | Physical Function Impairment and Frailty in Middle-Aged People Living With Human Immunodeficiency Virus in the REPRIEVE Trial Ancillary Study PREPARE. | J Infect Dis | 2020 |
| 32645161 | Leveraging a Landmark Trial of Primary Cardiovascular Disease Prevention in Human Immunodeficiency Virus: Introduction From the REPRIEVE Coprincipal Investigators. | J Infect Dis | 2020 |
| 32645160 | Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum. | J Infect Dis | 2020 |
| 32645158 | Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial. | J Infect Dis | 2020 |
| 30789450 | The Use of the Restricted Mean Survival Time as a Treatment Measure in HIV/AIDS Clinical Trial: Reanalysis of the ACTG A5257 Trial. | Journal of acquired immune deficiency syndromes (1999) | 2019 |
| 30219823 | Safety and Impact of Low-dose Methotrexate on Endothelial Function and Inflammation in Individuals With Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314. | Clin Infect Dis | 2019 |
| 30535188 | A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection. | Clinical Infectious Diseases | 2019 |
| 30184104 | Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical Trial. | Clin Infect Dis | 2019 |
| 30928825 | Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE). | Am Heart J | 2019 |
| 30928823 | Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers. | Am Heart J | 2019 |
| 31085814 | Vitamin D does not modulate immune-mediated bone loss during ART initiation. | Antiviral Therapy | 2019 |
| 30793009 | Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy. | Open Forum Infect Dis | 2019 |
| 30571173 | Brachial Artery Echogenicity and Grayscale Texture Changes in HIV-Infected Individuals Receiving Low-Dose Methotrexate. | Arterioscler Thromb Vasc Biol | 2018 |
| 27740537 | Hyperlipidaemia in HIV-infected patients on lopinavir/ritonavir monotherapy in resource-limited settings. | Antiviral Therapy | 2017 |
| 28832406 | Racial differences in calculated bioavailable vitamin D with vitamin D/calcium supplementation. | AIDS | 2017 |
| 29255724 | Vitamin D Supplementation Does Not Affect Metabolic Changes Seen With ART Initiation. | Open Forum Infect Dis | 2017 |
| 27661466 | Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s. | Antivir Ther | 2017 |